| |
| |
|
| Insider
Information: |
Guinan Mark |
| Relationship: |
Director |
| City: |
Batesville |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
339,229 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,227,309 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
339,229 |
|
|
| Total
Value |
$14,227,309 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hillenbrand Industries Inc |
HB |
|
2012-12-14 |
19,036 |
2010-12-21 |
0 |
Premium* |
|
|
Quest Diagnostics Inc |
DGX |
Executive Vice Preside... |
2022-03-07 |
98,981 |
2013-08-19 |
0 |
Premium* |
|
|
UpHealth, Inc. |
UPH |
Director |
2024-01-31 |
221,212 |
2022-12-16 |
0 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
Director |
2023-03-10 |
0 |
2023-03-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DGX |
Quest Diagnostics Inc |
Executive Vice President & CFO |
• – – |
2022-02-23 |
4 |
D |
$130.09 |
$308,020 |
D/D |
(2,367) |
86,425 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Executive Vice President & CFO |
• – – |
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,251 |
88,676 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Executive Vice President & CFO |
• – – |
2022-03-07 |
4 |
D |
$130.09 |
$1,362,693 |
D/D |
(10,475) |
98,981 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Executive Vice President & CFO |
• – – |
2022-03-07 |
4 |
A |
$130.09 |
$2,703,270 |
D/D |
20,780 |
109,456 |
0 |
- |
|
| HB |
Hillenbrand Industries In... |
Sr. VP and CFO |
• – – |
2010-12-21 |
4 |
A |
$41.85 |
$209,250 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| HB |
Hillenbrand Industries In... |
Sr. VP & CFO |
• – – |
2011-12-14 |
4 |
D |
$31.85 |
$100,073 |
D/D |
(3,142) |
12,132 |
0 |
- |
|
| HB |
Hillenbrand Industries In... |
Sr. VP & CFO |
• – – |
2011-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,274 |
15,274 |
0 |
- |
|
| HB |
Hillenbrand Industries In... |
Sr. VP & CFO |
• – – |
2012-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,127 |
22,259 |
0 |
- |
|
| HB |
Hillenbrand Industries In... |
Sr. VP & CFO |
• – – |
2012-12-14 |
4 |
D |
$28.98 |
$93,403 |
D/D |
(3,223) |
19,036 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Director |
– • – |
2023-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,673) |
0 |
0 |
- |
|
| UPH |
UpHealth, Inc. |
Director |
– • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
60,606 |
60,606 |
0 |
- |
|
| UPH |
UpHealth, Inc. |
Director |
– • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
160,606 |
0 |
- |
|
62 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
